Connote Healthcare Private Limited

Naltrexone Tablets USP 50 mg contain Naltrexone Hydrochloride, an opioid antagonist that adheres to United States Pharmacopeia (USP) standards, ensuring its quality and potency. This medication is primarily used as an adjunctive therapy within a comprehensive treatment program for alcohol dependence and opioid dependence. Naltrexone works by blocking the effects of opioid receptors in the brain, which in turn reduces the euphoric "high" associated with opioid use and also helps to curb cravings for both alcohol and opioids. It is important to note that Naltrexone is not a cure for addiction but rather a tool to aid in maintaining abstinence. For alcohol dependence, the usual recommended dose is 50 mg orally once daily. For opioid dependence, treatment typically begins with a lower dose, often 25 mg, to ensure the patient is opioid-free and does not experience withdrawal symptoms, followed by an increase to 50 mg once daily. It is crucial that patients are completely opioid-free for at least 7-10 days before initiating Naltrexone treatment to avoid precipitating acute opioid withdrawal. Naltrexone tablets should be swallowed whole and can be taken with food if stomach upset occurs. These tablets should be stored at controlled room temperature, typically 20°C to 25°C (68°F to 77°F), with excursions permitted to 15°C to 30°C (59°F to 86°F), in a tight container protected from excess heat and moisture.